A Bioavailability Study of MIV-711 Oral Formulations in Healthy Volunteers
Completed · Phase 1
Conditions studied: Healthy
In brief
This is a single-Center, Randomised, 4-Period, Phase 1 Study to Evaluate the Pharmacokinetics, Safety and Tolerability, and Effect of Food on Pharmacokinetics following Single Doses of MIV-711 Capsule and Tablet Formulations in Healthy Volunteers
Key facts
- Study ID
- NCT03443453
- Run by
- Medivir
- People needed
- 18
- Starts
- 2018-01-19
- Expected to finish
- 2018-02-17
- Last updated by the study team
- 2018-02-23
Who can join
Age: 19 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- Celerion — Lincoln, Nebraska, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.